PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Growth Recovery Among Asian Children With Perinatally Acquired HIV Infection on First-Line Combination Antiretroviral TherapyView Poster
AbstractHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Growth recovery among Asian children with perinatally acquired HIV infection on first-line combination antiretroviral therapyView Abstract
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Immune Profile of COVID-19 Patients Treated With Corticosteroids vs Anti-Interleukin 6 (Tocilizumab) For Cytokine Release Syndrome.View Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Association Between the Levels of Serum Free Testosterone Levels and Lifestyle-Related Diseases in People Living With HIVView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Prevalence of Hypogonadism Among People Living With HIV in TaiwanView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Prevalence of Hypogonadism Among People Living With HIV in TaiwanView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Collaborative Care Model to Facilitate Integration of Mental Healthcare Into HIV Treatment and Prevention Services for Adolescents and Young Adults in Bangkok, ThailandView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Real-World Effectiveness, Safety and Tolerability of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/Taf) In Routine Clinical Practice in People Living With HIV (Plwh), ChinaView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In Treatment Experienced Patients – Asian Real-World ExperienceView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Cost-Effectiveness of Dtg/3tc for Human Immunodeficiency Virus (HIV-1) Infection Treatment in TaiwanView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Efficacy, Safety and Tolerability of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) Among People Living With HIV in a Real-World SettingView Poster
PosterHIVViral Hepatitis and Liver DiseaseRSVTuberculosisAPACC 2021Durable Efficacy of Dolutegravir (Dtg) Plus Lamivudine (3tc) In Antiretroviral Treatment–Naive Adults With HIV-1 Infection: 3-Year Results From the Gemini Studies in Participants From Asian CentersView Poster
